Wilbanks Smith & Thomas Asset Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.13M | Sell |
7,370
-65
| -0.9% | -$9.7K | 0.03% | 216 |
|
|
2023
Q4 | $1.06M | Sell |
7,435
-11,140
| -60% | -$1.49M | 0.03% | 216 |
|
|
2023
Q3 | $2.43M | Sell |
18,575
-1,220
| -6% | -$185K | 0.08% | 140 |
|
|
2023
Q2 | $3.15M | Sell |
19,795
-100
| -0.5% | -$16.1K | 0.1% | 128 |
|
|
2023
Q1 | $3.15M | Buy |
19,895
+1,056
| +6% | +$158K | 0.11% | 126 |
|
|
2022
Q4 | $2.64M | Buy |
18,839
+1,050
| +6% | +$149K | 0.1% | 135 |
|
|
2022
Q3 | $2.28M | Buy |
17,789
+923
| +5% | +$133K | 0.1% | 135 |
|
|
2022
Q2 | $2.38M | Buy |
16,866
+943
| +6% | +$135K | 0.1% | 138 |
|
|
2022
Q1 | $2.35M | Buy |
15,923
+3,117
| +24% | +$478K | 0.09% | 144 |
|
|
2021
Q4 | $2.23M | Buy |
12,806
+6,432
| +101% | +$1.07M | 0.08% | 156 |
|
|
2021
Q3 | $1.06M | Buy |
6,374
+1
| +0% | +$172 | 0.04% | 219 |
|
|
2021
Q2 | $1.15M | Buy |
6,373
+158
| +3% | +$28.8K | 0.05% | 211 |
|
|
2021
Q1 | $1.2M | Sell |
6,215
-2,370
| -28% | -$456K | 0.05% | 195 |
|
|
2020
Q4 | $1.73M | Buy |
8,585
+312
| +4% | +$64.6K | 0.08% | 150 |
|
|
2020
Q3 | $1.74M | Buy |
8,273
+2,574
| +45% | +$573K | 0.09% | 145 |
|
|
2020
Q2 | $1.25M | Buy |
5,699
+39
| +0.7% | +$7.79K | 0.08% | 150 |
|
|
2020
Q1 | $981K | Buy |
5,660
+195
| +4% | +$32.2K | 0.07% | 164 |
|
|
2019
Q4 | $839K | Hold |
5,465
| – | – | 0.05% | 187 |
|
|
2019
Q3 | $830K | Sell |
5,465
-100
| -2% | -$15.8K | 0.05% | 181 |
|
|
2019
Q2 | $852K | Hold |
5,565
| – | – | 0.05% | 181 |
|
|
2019
Q1 | $893K | Hold |
5,565
| – | – | 0.06% | 176 |
|
|
2018
Q4 | $858K | Sell |
5,565
-645
| -10% | -$100K | 0.06% | 157 |
|
|
2018
Q3 | $934K | Buy |
6,210
+271
| +5% | +$38.5K | 0.06% | 174 |
|
|
2018
Q2 | $803K | Sell |
5,939
-126
| -2% | -$15.6K | 0.06% | 153 |
|
|
2018
Q1 | $807K | Sell |
6,065
-4
| -0.1% | -$537 | 0.06% | 151 |
|
|
2017
Q4 | $903K | Buy |
6,069
+379
| +7% | +$51.6K | 0.07% | 147 |
|
|
2017
Q3 | $751K | Buy |
5,690
+32
| +0.6% | +$4.3K | 0.06% | 157 |
|
|
2017
Q2 | $754K | Sell |
5,658
-15
| -0.3% | -$2.02K | 0.07% | 154 |
|
|
2017
Q1 | $765K | Sell |
5,673
-428
| -7% | -$55.4K | 0.07% | 150 |
|
|
2016
Q4 | $732K | Buy |
6,101
+1,141
| +23% | +$135K | 0.07% | 147 |
|
|
2016
Q3 | $621K | Sell |
4,960
-1,600
| -24% | -$210K | 0.06% | 154 |
|
|
2016
Q2 | $908K | Hold |
6,560
| – | – | 0.09% | 132 |
|
|
2016
Q1 | $827K | Sell |
6,560
-460
| -7% | -$58.5K | 0.1% | 133 |
|
|
2015
Q4 | $890K | Buy |
7,020
+1,495
| +27% | +$186K | 0.09% | 127 |
|
|
2015
Q3 | $638K | Sell |
5,525
-1,600
| -22% | -$180K | 0.09% | 127 |
|
|
2015
Q2 | $741K | Hold |
7,125
| – | – | 0.07% | 145 |
|
|
2015
Q1 | $787K | Hold |
7,125
| – | – | 0.08% | 135 |
|
|
2014
Q4 | $742K | Hold |
7,125
| – | – | 0.08% | 144 |
|
|
2014
Q3 | $684K | Buy |
7,125
+94
| +1% | +$8.5K | 0.07% | 135 |
|
|
2014
Q2 | $643K | Hold |
7,031
| – | – | 0.07% | 149 |
|
|
2014
Q1 | $619K | Buy |
7,031
+1,366
| +24% | +$120K | 0.07% | 149 |
|
|
2013
Q4 | $525K | Sell |
5,665
-1,258
| -18% | -$113K | 0.06% | 168 |
|
|
2013
Q3 | $566K | Buy |
6,923
+1,694
| +32% | +$143K | 0.08% | 149 |
|
|
2013
Q2 | $435K | Buy |
+5,229
| New | +$450K | 0.07% | 163 |
|
Other funds holding CLX
CIP
Wilbanks Smith & Thomas Asset Management's CLX Position: Q1 2024 in Review
Wilbanks Smith & Thomas Asset Management reduced its Clorox (CLX) stake by 0.87% in Q1 2024, selling an estimated $9.7K and leaving 7,370 shares worth $1.13M. The position accounts for 0.03% of the portfolio, ranked #216.
Wilbanks Smith & Thomas Asset Management first reported a position in CLX in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.15M in Q2 2023. 1,144 funds tracked by Wall St. Rank hold CLX as of Q1 2024.
- Wilbanks Smith & Thomas Asset Management held 7,370 shares of Clorox worth $1.13M as of Q1 2024.
- Wilbanks Smith & Thomas Asset Management sold 65 Clorox shares in Q1 2024, an estimated $9.7K.
- Clorox made up 0.03% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #216 holding.
- Wilbanks Smith & Thomas Asset Management first reported a position in Clorox in Q2 2013 and has held it in 44 quarters since.
- Wilbanks Smith & Thomas Asset Management's Clorox position peaked at $3.15M in Q2 2023.
- 1,144 funds tracked by Wall St. Rank held Clorox as of Q1 2024.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.